Company Profile
Bicycle Therapeutics Stock Price, News & Analysis
- Ticker:
- BCYC
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United Kingdom with U
Stock performance
3.97 USD (0.00%)
Close
Last updated: August 6, 2026
300M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, BCYC was little changed and closed at $3.97. No new same-company headline was identified in the current news window.
Company overview
Business overview
Bicycle Therapeutics is a precision-oncology company focused on bicyclic peptide therapeutics and targeted cancer biology. Its platform seeks to pair selectivity with tumor targeting.
Geographic Base and Sector Classification
Headquartered in the United Kingdom with U.S. market exposure and listed on NASDAQ as an ADR, Bicycle is a global oncology biotech.
Business Model Characteristics
The company depends on clinical data, platform validation, and the possibility of building a differentiated targeted-cancer franchise.
Position Within the Biotechnology Landscape
Bicycle is a high-quality platform oncology name whose valuation hinges on translational and clinical progress.
Future catalysts
Bicycle Therapeutics's catalysts are BT8009 and BT5528, with oncology data driving whether the platform can still justify premium expectations. The next readout matters a lot because the platform story is still being judged.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Bicycle Therapeutics (BCYC)?
Bicycle Therapeutics (BCYC) most recently closed at 3.97 USD, a 0.00% move versus the previous session.
What is the market cap of Bicycle Therapeutics (BCYC)?
Bicycle Therapeutics currently has a market capitalization of 300M USD on BioPharmSignal.
What does Bicycle Therapeutics do?
Bicycle Therapeutics is a precision-oncology company focused on bicyclic peptide therapeutics and targeted cancer biology. Its platform seeks to pair selectivity with tumor targeting.
On which exchange is BCYC stock listed?
Bicycle Therapeutics (BCYC) is associated with NASDAQ, United Kingdom with U, Biopharma.
What is Bicycle?
Bicycle Therapeutics's catalysts are BT8009 and BT5528, with oncology data driving whether the platform can still justify premium expectations.
Which conditions is Bicycle Therapeutics targeting with Bicycle?
Bicycle Therapeutics is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Bicycle Therapeutics describe recent progress with Bicycle?
Bicycle Therapeutics's catalysts are BT8009 and BT5528, with oncology data driving whether the platform can still justify premium expectations.
What is Therapeutics?
Bicycle Therapeutics is a precision-oncology company focused on bicyclic peptide therapeutics and targeted cancer biology.